Segui
Andrew Watts
Andrew Watts
Senior Lecturer, University of Bath
Email verificata su bath.ac.uk
Titolo
Citata da
Citata da
Anno
Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog
CPC Chiu, AG Watts, LL Lairson, M Gilbert, D Lim, WW Wakarchuk, ...
Nature structural & molecular biology 11 (2), 163-170, 2004
2872004
Trypanosoma cruzi Trans-sialidase Operates through a Covalent Sialyl−Enzyme Intermediate:  Tyrosine Is the Catalytic Nucleophile
AG Watts, I Damager, ML Amaya, A Buschiazzo, P Alzari, AC Frasch, ...
Journal of the American Chemical Society 125 (25), 7532-7533, 2003
2872003
Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase
MF Amaya, AG Watts, I Damager, A Wehenkel, T Nguyen, A Buschiazzo, ...
Structure 12 (5), 775-784, 2004
2732004
Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity
JH Kim, R Resende, T Wennekes, HM Chen, N Bance, S Buchini, ...
Science 340 (6128), 71-75, 2013
2262013
The structure of Clostridium perfringens NanI sialidase and its catalytic intermediates
SL Newstead, JA Potter, JC Wilson, G Xu, CH Chien, AG Watts, ...
Journal of Biological Chemistry 283 (14), 9080-9088, 2008
1622008
A key role for redox signaling in rapid P2X7 receptor-induced IL-1β processing in human monocytes
J Hewinson, SF Moore, C Glover, AG Watts, AB MacKenzie
The Journal of Immunology 180 (12), 8410-8420, 2008
1482008
Structural and kinetic analysis of two covalent sialosyl-enzyme intermediates on Trypanosoma rangeli sialidase
AG Watts, P Oppezzo, SG Withers, PM Alzari, A Buschiazzo
Journal of Biological Chemistry 281 (7), 4149-4155, 2006
1162006
Conservation of structure and mechanism in primary and secondary transporters exemplified by SiaP, a sialic acid binding virulence factor from Haemophilus influenzae
A Muller, E Severi, C Mulligan, AG Watts, DJ Kelly, KS Wilson, ...
Journal of Biological Chemistry 281 (31), 22212-22222, 2006
1152006
Using substrate engineering to harness enzymatic promiscuity and expand biological catalysis
LL Lairson, AG Watts, WW Wakarchuk, SG Withers
Nature Chemical Biology 2 (12), 724-728, 2006
832006
Kinetic and Mechanistic Analysis of Trypanosoma cruzi Trans-Sialidase Reveals a Classical Ping-Pong Mechanism with Acid/Base Catalysis
I Damager, S Buchini, MF Amaya, A Buschiazzo, P Alzari, AC Frasch, ...
Biochemistry 47 (11), 3507-3512, 2008
812008
The synthesis of some mechanistic probes for sialic acid processing enzymes and the labeling of a sialidase from Trypanosoma rangeli
AG Watts, SG Withers
Canadian journal of chemistry 82 (11), 1581-1588, 2004
702004
Characterization of reactions between water-soluble trialkylphosphines and thiol alkylating reagents: implications for protein-conjugation reactions
T Kantner, AG Watts
Bioconjugate Chemistry 27 (10), 2400-2406, 2016
552016
The Aspergillus fumigatus sialidase is a 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid hydrolase (KDNase): structural and mechanistic insights
JC Telford, JHF Yeung, G Xu, MJ Kiefel, AG Watts, S Hader, J Chan, ...
Journal of Biological Chemistry 286 (12), 10783-10792, 2011
482011
Tripartite ATP-independent periplasmic (TRAP) transporters use an arginine-mediated selectivity filter for high affinity substrate binding
M Fischer, AP Hopkins, E Severi, J Hawkhead, D Bawdon, AG Watts, ...
Journal of Biological Chemistry 290 (45), 27113-27123, 2015
432015
High PD-1/PD-L1 checkpoint interaction infers tumor selection and therapeutic sensitivity to anti-PD-1/PD-L1 treatment
L Sánchez-Magraner, J Miles, CL Baker, CJ Applebee, DJ Lee, ...
Cancer Research 80 (19), 4244-4257, 2020
422020
2, 3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
S Withers, AG Watts, JH Kim, T Wennekes
US Patent 8,815,941, 2014
392014
Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments
S Withers, AG Watts, JH Kim, T Wennekes
US Patent 8,907,111, 2014
372014
2, 3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
S Withers, AG Watts, JH Kim, T Wennekes
US Patent 9,221,859, 2015
352015
Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments
S Withers, AG Watts, JH Kim, T Wennekes
US Patent 9,382,284, 2016
342016
In situ quenching of trialkylphosphine reducing agents using water-soluble PEG-azides improves maleimide conjugation to proteins
T Kantner, B Alkhawaja, AG Watts
ACS omega 2 (9), 5785-5791, 2017
302017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20